|The CA19-9 Cancer Antigen n/a (Catalog #MBS600178) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The CA19-9 Cancer Antigen (Pancreatic, GI or Ovarian Tumor Antigen, Sialyl Lewis a) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s CA19-9 Cancer Antigen can be used in a range of immunoassay formats including, but not limited to, ELISA (EL/EIA), Immunohistochemistry (IHC).
Immunohistology (Formalin/paraffin): (Use Ab at 1:10-1:20 for 30 min at RT) No special pretreatment is required for staining of formalin-fixed, paraffin-embedded tissues. Researchers should empirically determine the suitability of the CA19-9 Cancer Antigen n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process. The amino acid sequence is listed below:
Sialic acid-conta ining residue of the monosialog anglioside (3).
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Sialyl Lea is synthesized from type 1 blood group precursor chains and is present in individuals expressing the Lea and/or Leb blood group antigens.
Immunogen: Human colon carcinoma cell line SW11162.
Cellular Localization: Cell membrane. Positive Control: Colon carcinoma. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing CA19-9 Cancer Antigen are readily searchable from our website. Different antibodies against the same target such as CA19-9 Cancer Antigen may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.